Human gene therapy - JoVE Visualize

Showing results (1-10 of 4,122) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|November 11, 2014

Aerosol-mediated delivery of AAV2/6-IκBα attenuates lipopolysaccharide-induced acute lung injury in ratsRonan J MacLoughlin, Brendan D Higgins, James Devaney, et al.

Human Gene Therapy|November 25, 2014

Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma modelTiffany T Huang, Shraddha Parab, Ryan Burnett, et al.

Human Gene Therapy|June 15, 2016

Naturally Existing Oncolytic Virus M1 Is Nonpathogenic for the Nonhuman Primates After Multiple Rounds of Repeated Intravenous InjectionsHaipeng Zhang, Yuan Lin, Kai Li, et al.

Human Gene Therapy|March 5, 2016

Disruption of Microtubules Post-Virus Entry Enhances Adeno-Associated Virus Vector TransductionPing-Jie Xiao, Angela M Mitchell, Lu Huang, et al.

Human Gene Therapy|March 27, 2013

Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosisBalakrishnan Chakrapani Narmada, Yuzhan Kang, Lakshmi Venkatraman, et al.

Human Gene Therapy|December 30, 2014

Fanconi anemia gene editing by the CRISPR/Cas9 systemMark J Osborn, Richard Gabriel, Beau R Webber, et al.

Human Gene Therapy|January 6, 2015

Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirusMari Hirvinen, Maria Rajecki, Mika Kapanen, et al.

Human Gene Therapy|June 8, 2012

Recent progress in gene therapy for hemophiliaMarinee K Chuah, Nisha Nair, Thierry VandenDriessche

Human Gene Therapy|March 23, 2013

Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primatesLluis Samaranch, Ernesto A Salegio, Waldy San Sebastian, et al.

Human Gene Therapy|March 23, 2013

Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012Marina O'Reilly, Donald B Kohn, Jeffrey Bartlett, et al.

Pageof 413

Showing results (1-10 of 4,122) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|November 11, 2014

Aerosol-mediated delivery of AAV2/6-IκBα attenuates lipopolysaccharide-induced acute lung injury in ratsRonan J MacLoughlin, Brendan D Higgins, James Devaney, et al.

Human Gene Therapy|November 25, 2014

Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma modelTiffany T Huang, Shraddha Parab, Ryan Burnett, et al.

Human Gene Therapy|June 15, 2016

Naturally Existing Oncolytic Virus M1 Is Nonpathogenic for the Nonhuman Primates After Multiple Rounds of Repeated Intravenous InjectionsHaipeng Zhang, Yuan Lin, Kai Li, et al.

Human Gene Therapy|March 5, 2016

Disruption of Microtubules Post-Virus Entry Enhances Adeno-Associated Virus Vector TransductionPing-Jie Xiao, Angela M Mitchell, Lu Huang, et al.

Human Gene Therapy|March 27, 2013

Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosisBalakrishnan Chakrapani Narmada, Yuzhan Kang, Lakshmi Venkatraman, et al.

Human Gene Therapy|December 30, 2014

Fanconi anemia gene editing by the CRISPR/Cas9 systemMark J Osborn, Richard Gabriel, Beau R Webber, et al.

Human Gene Therapy|January 6, 2015

Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirusMari Hirvinen, Maria Rajecki, Mika Kapanen, et al.

Human Gene Therapy|June 8, 2012

Recent progress in gene therapy for hemophiliaMarinee K Chuah, Nisha Nair, Thierry VandenDriessche

Human Gene Therapy|March 23, 2013

Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primatesLluis Samaranch, Ernesto A Salegio, Waldy San Sebastian, et al.

Human Gene Therapy|March 23, 2013

Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012Marina O'Reilly, Donald B Kohn, Jeffrey Bartlett, et al.

Pageof 413